Documento fuente o registro público

FDA 510(k) K201217 — HemoCue Hb 301 System

FDA 510(k) index record K201217. Device: HemoCue Hb 301 System. Applicant as listed: Hemocue AB. Decision date: 2020-08-04.

OtherU.S. Food and Drug Administration (FDA)2020-08-04

Fuente

"device_name": "HemoCue Hb 301 System"

Esta entrada describe lo que cubre el documento; el propio documento es la autoridad. Incluirlo no implica estar de acuerdo con sus conclusiones.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K201217.

Device name: HemoCue Hb 301 System. Applicant as listed: Hemocue AB.

Decision date: 2020-08-04. Decision wording: Substantially Equivalent.

Product code: GKR. Regulation: 21 CFR 864.5620. Medical specialty: Hematology.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.

Explorar más